8th Edition of Euro-Global Conference on Pediatrics and Neonatology
September 28-30, 2026
London, UK
#Pediatrics #Neonatology #PrimaryCare #Vaccinology #Immunotherapy
#PediatricsConference #MedicalConference
@vydyahealth.bsky.social
@vydyahealth.bsky.social8th Edition of Euro-Global Conference on Pediatrics and Neonatology
September 28-30, 2026
London, UK
#Pediatrics #Neonatology #PrimaryCare #Vaccinology #Immunotherapy
#PediatricsConference #MedicalConference
@science.orgNew results in #ScienceSignaling reveal that the T cell adaptor protein PAG supports the function of #TCell immune synapses by connecting with actin, suggesting that it could offer a target to improve #immunotherapy in patients that show poor responses. https://scim.ag/3V1ilCa
@gmj-georgia.bsky.social🔬 Researchers have identified how immune cells trigger kidney damage in lupus. A new study in Science Translational Medicine reveals that CD8+ T ce… #Autoimmunedisease #CD8Tcells #Immunotherapy #Kidneyinflammation #Lupusnephritis #Autoimmunedisease #CD8Tcells #Immunotherapy #Kidneyinflammation …
@vaccinologist.bsky.social🧪 @columbiauniversity.bsky.social engineered E. coli act as “drug factories” inside tumors - a fascinating #syntheticbiology approach. By converting 5-FC to 5-FU locally & delivering #immunotherapy payloads, it combines targeted #chemotherapy & immune activation www.linkedin.com/posts/drmelv...
@subhammridha.bsky.socialOur results demonstrate that a combinatorial immune-microbiota-based approach can treat infections. This is just the trailer, stay tuned for the final show!! Real team effort, I am grateful to all people involved in this study @upenn.edu #Immunotherapy #Microbiome #MicrobiotaBasedTherapy #Cdiff
@molneurodegenadvnc.bsky.socialConformation-specific anti-pathological tau #antibody raised against AD brain-derived seed-competent tau reduces tau pathology in transgenic mice
Kiran Yanamandra, Nandini Romanul, Hiral Patel...Xavier Langlois #AlzheimersDisease #immunotherapy
@genesndiseases.bsky.socialMitochondrial redox balance could reveal new cancer clues.
This pan-cancer study links SLC25A39 to tumor progression, immune checkpoints and #immunotherapy response, highlighting its #biomarker potential. #GastricCancer
#OpenAccess in #GenesAndDiseases: doi.org/10.1016/j.ge...
@isev.org🆕New in #JExBio🆕 Natural Killer Cell-Derived Extracellular Vesicle Preparations Demonstrate Potent Antitumor Activity Against Human Glioblastoma In Vitro and In Vivo #extracellularvesicles #immunotherapy #glioblastoma #naturalkillercells isevjournals.onlinelibrary.wiley.com/doi/epdf/10....
@natmed.nature.comIntegrating numerous multimodal, patient-level biomarkers enhances the prediction of #cancer #immunotherapy response, but generalizability is still a challenge.
News & Views from Raquel Perez-Lopez, Mireia Crispin-Ortuzar @CRUKCamCentre @VHIO
@pharmaj.bsky.socialIn this feature article #RobBrown highlights how the approval of #teplizumab could be “the biggest breakthrough since the discovery of insulin” in #diabetes treatment and researchers hope it could lead to a “functional cure”
@newsen.bsky.socialBladder Cancer Treatment Market Expected to Surge to USD 11.33 Billion by 2034 Amid Increasing Incidence and Innovative Therapies #India #Immunotherapy #Pune #Bladder_Cancer #Targeted_Therapy
@ontarget-podcast.bsky.socialMirna Jarosz, CEO of #LiquidCellDx, explains how her company's #liquidbiopsy captures information about the #tumormicroenvironment, providing critical treatment guidance.
🎧 Listen now → www.ontargetpodcast.com
#OnTarget #PrecisionMedicine #Oncology #Immunotherapy #CancerDiagnostics #AI
@scienceinboston.comResearchers at @harvardmed.bsky.social and @danafarber.bsky.social have found that CDK2 inhibitors reduce resistance to #immunotherapy across a wide range of cancers.
📝 Abstract: https://bit.ly/4A9K5nU
📰 Press release: https://bit.ly/4diAUrR
@gmj-georgia.bsky.socialA phase 2 trial of teclistamab-based induction therapy in newly diagnosed multiple myeloma has been published in Nature Medicine with an aut… #Bispecificantibodies #Clinicaltrial #Immunotherapy #Multiplemyeloma #Teclistamab #Bispecificantibodies #Clinicaltrial #Immunotherapy #Multiplemyeloma #T…
@immunopaedia.bsky.social#ImmunologyNews Immune checkpoint inhibitors (ICIs) have transformed cancer treatment by releasing the brakes on anti-tumour T cells...#cancer #immunotherapy #immunology
Read more here: https://ow.ly/3vP550ZPrxU
@arcportal.org.auA world first multi indication PBS listing for nivolumab and ipilimumab now covers all immunotherapy sensitive advanced or metastatic cancers, regardless of tumour type.
Read more: https://www.arcportal.org.au/new-pbs-listing-for-immunotherapy-access
@moltherapy.bsky.socialListen to the latest episode of the Molecular Therapy podcast, Advancements in Pediatric Cancer Therapy: http://dlvr.it/TVbR90
@imtadvances.bsky.socialNew research shows that adding CD28 signalling motifs to the CD3ζ chain boosts IL‑2 production and expansion of TCR‑engineered T cells, without reducing cytotoxicity. A promising step toward stronger TCR therapies for solid tumours.
Read here: vist.ly/5jcu9
@thecancersurvivorsclub.comA new ovarian cancer trial is testing a different way to harness the immune system. NTB-928 is designed to redirect a patient’s own T cells to recognise and attack cancer cells.
@gmj-georgia.bsky.socialScience Translational Medicine has issued a formal erratum for research on GDP-mannose and triple-negative breast cancer therapy. The correc… #Cancerresearch #GDPmannose #Immunotherapy #Translationalmedicine #Triplenegativebreastcancer #Cancerresearch #GDPmannose #Immunotherapy #Translationalme…